Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
China - Hong Kong SAR 1996-2001331867.454.148.969.558.856.161.664.7
China - Qidong 1992-200031226.316.812.327.018.013.913.113.4
China - Shangai 1992-1995127156.339.235.157.741.939.243.345.6
China - Tianjin 1991-1999148160.146.542.861.649.848.051.153.2
Cuba 1994-199546466.347.543.567.449.947.349.450.3
Gambia 1993-19974939.824.424.440.325.225.422.525.5
India - Barshi 1993-20003641.727.822.242.530.025.424.125.9
India - Bhopal 1991-19953033.316.710.033.917.310.58.89.9
India - Chennai 1990-199986850.230.321.651.332.123.621.523.2
India - Karunagappally 1991-19976952.234.625.554.438.830.436.039.8
India - Mumbai 1992-1994233850.338.030.251.841.134.134.237.1
Singapore 1993-199779059.545.942.561.149.047.149.252.0
Republic of Korea - Busan 1996-200178566.950.343.267.852.346.246.649.0
Republic of Korea - Incheon 1997-200148370.353.050.971.455.254.253.857.4
Republic of Korea - Seoul 1993-1997168071.357.453.572.359.657.056.758.0
Thailand - Chiang Mai 1993-199729851.932.425.452.233.026.326.028.1
Thailand - Khon Kaen 1993-199716863.346.638.263.847.740.042.039.3
Thailand - Lampang 1990-200036858.245.440.158.846.842.343.644.3
Thailand - Songkhla 1990-199931963.946.541.864.547.843.845.647.7
Turkey - Izmir 1995-199734472.651.045.173.953.849.549.850.6
Uganda - Kampala 1993-199717861.440.731.962.342.233.626.125.1



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period